These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 32588133)
1. Low level of microsatellite instability correlates with short disease-free survival of gastric cancer patients undergoing neoadjuvant chemotherapy. Jiang D; Shu C; Zhang W; Sun L; Zhang M; He Y; Owen G; Jin W; He D; Deng X; Liu X Virchows Arch; 2021 Feb; 478(2):231-240. PubMed ID: 32588133 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant Chemotherapy in Microsatellite Instability-High Gastric Cancer. Kim JW; Cho SY; Chae J; Kim JW; Kim TY; Lee KW; Oh DY; Bang YJ; Im SA Cancer Res Treat; 2020 Oct; 52(4):1178-1187. PubMed ID: 32599979 [TBL] [Abstract][Full Text] [Related]
3. Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer. Pietrantonio F; Miceli R; Raimondi A; Kim YW; Kang WK; Langley RE; Choi YY; Kim KM; Nankivell MG; Morano F; Wotherspoon A; Valeri N; Kook MC; An JY; Grabsch HI; Fucà G; Noh SH; Sohn TS; Kim S; Di Bartolomeo M; Cunningham D; Lee J; Cheong JH; Smyth EC J Clin Oncol; 2019 Dec; 37(35):3392-3400. PubMed ID: 31513484 [TBL] [Abstract][Full Text] [Related]
4. Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses. Park SH; Sohn TS; Lee J; Lim DH; Hong ME; Kim KM; Sohn I; Jung SH; Choi MG; Lee JH; Bae JM; Kim S; Kim ST; Park JO; Park YS; Lim HY; Kang WK J Clin Oncol; 2015 Oct; 33(28):3130-6. PubMed ID: 25559811 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of microsatellite instability in patients with resectable gastric cancer. Pereira MA; Ramos MFKP; Cardili L; Dias AR; Alves VAF; de Mello ES; Ribeiro U J Gastrointest Surg; 2024 Oct; 28(10):1687-1695. PubMed ID: 39147611 [TBL] [Abstract][Full Text] [Related]
6. Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy. Li Z; Jia Y; Zhu H; Xing X; Pang F; Shan F; Li S; Wang D; Zhao F; Ma T; Wang S; Ji J Gastric Cancer; 2021 Nov; 24(6):1342-1354. PubMed ID: 34406546 [TBL] [Abstract][Full Text] [Related]
8. A Multi-cohort Study of the Prognostic Significance of Microsatellite Instability or Mismatch Repair Status after Recurrence of Resectable Gastric Cancer. An JY; Choi YY; Lee J; Hyung WJ; Kim KM; Noh SH; Choi MG; Cheong JH Cancer Res Treat; 2020 Oct; 52(4):1153-1161. PubMed ID: 32599987 [TBL] [Abstract][Full Text] [Related]
9. Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled study. Choi YY; Kim H; Shin SJ; Kim HY; Lee J; Yang HK; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Choi SH; Hong S; Kim JW; Hyung WJ; Noh SH; Cheong JH Ann Surg; 2019 Aug; 270(2):309-316. PubMed ID: 29727332 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy. Haag GM; Czink E; Ahadova A; Schmidt T; Sisic L; Blank S; Heger U; Apostolidis L; Berger AK; Springfeld C; Lasitschka F; Jäger D; von Knebel Doeberitz M; Kloor M Int J Cancer; 2019 Apr; 144(7):1697-1703. PubMed ID: 30499151 [TBL] [Abstract][Full Text] [Related]
11. Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein-Barr virus infection and high- and low-microsatellite instability. Kohlruss M; Grosser B; Krenauer M; Slotta-Huspenina J; Jesinghaus M; Blank S; Novotny A; Reiche M; Schmidt T; Ismani L; Hapfelmeier A; Mathias D; Meyer P; Gaida MM; Bauer L; Ott K; Weichert W; Keller G J Pathol Clin Res; 2019 Oct; 5(4):227-239. PubMed ID: 31206244 [TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake? Reddavid R; Sofia S; Chiaro P; Colli F; Trapani R; Esposito L; Solej M; Degiuli M World J Gastroenterol; 2018 Jan; 24(2):274-289. PubMed ID: 29375213 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of microsatellite instability in sporadic locally advanced rectal cancer following neoadjuvant radiotherapy. Du C; Zhao J; Xue W; Dou F; Gu J Histopathology; 2013 Apr; 62(5):723-30. PubMed ID: 23425253 [TBL] [Abstract][Full Text] [Related]
14. Molecular features and prognostic factors of locally advanced microsatellite instability-high gastric cancer. Furukawa K; Hatakeyama K; Terashima M; Urakami K; Koseki Y; Fujiya K; Tanizawa Y; Bando E; Yamaguchi K Gastric Cancer; 2024 Jul; 27(4):760-771. PubMed ID: 38744779 [TBL] [Abstract][Full Text] [Related]
15. Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA-S Trial. Di Bartolomeo M; Morano F; Raimondi A; Miceli R; Corallo S; Tamborini E; Perrone F; Antista M; Niger M; Pellegrinelli A; Randon G; Pagani F; Martinetti A; Fucà G; Pietrantonio F; Oncologist; 2020 Mar; 25(3):e460-e468. PubMed ID: 32162808 [TBL] [Abstract][Full Text] [Related]
16. Prognostic and predictive impact of sex in locally advanced microsatellite instability high gastric or gastroesophageal junction cancer: An individual patient data pooled analysis of randomized clinical trials. Raimondi A; Kim YW; Kang WK; Langley RE; Choi YY; Kim KM; Nankivell MG; Randon G; Kook MC; An JY; Grabsch HI; Prisciandaro M; Nichetti F; Noh SH; Sohn TS; Kim S; Wotherspoon A; Morano F; Cunningham D; Lee J; Cheong JH; Smyth EC; Pietrantonio F Eur J Cancer; 2024 May; 203():114043. PubMed ID: 38598921 [TBL] [Abstract][Full Text] [Related]
17. Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial. Roh CK; Choi YY; Choi S; Seo WJ; Cho M; Jang E; Son T; Kim HI; Kim H; Hyung WJ; Huh YM; Noh SH; Cheong JH Yonsei Med J; 2019 Feb; 60(2):132-139. PubMed ID: 30666834 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial. Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; van Berge Henegouwen MI; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M; Lancet Oncol; 2018 May; 19(5):616-628. PubMed ID: 29650363 [TBL] [Abstract][Full Text] [Related]
19. A greater lymph node yield is required during pathological examination in microsatellite instability-high gastric cancer. Cai Z; Song H; Fingerhut A; Sun J; Ma J; Zhang L; Li S; Yu C; Zheng M; Zang L BMC Cancer; 2021 Mar; 21(1):319. PubMed ID: 33765970 [TBL] [Abstract][Full Text] [Related]
20. Expression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1. Pereira MA; Ramos MFKP; Dias AR; Faraj SF; Ribeiro RRE; de Castria TB; Zilberstein B; Alves VAF; Ribeiro U; de Mello ES Mol Diagn Ther; 2019 Dec; 23(6):761-771. PubMed ID: 31595457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]